First discovered in 1973, HMGB1 is presumably released from dead cells and secreted by inflammatory cells, and HMGB1 plays central roles in various disease states [16], including autoimmune disease [17], ischemia reperfusion injury [18], inflammation, and cancer [19, 20]. Here, HMGB1 is linked to autoimmune disease.